B of A Securities analyst Bryan Spillane maintains General Mills (NYSE:GIS) with a Neutral and raises the price target from $74 to $81.
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
Ratings for Ionis Pharmaceuticals (NASDAQ:IONS) were provided by 8 analysts in the past three months, showcasing a mix…